Latest news for Renaissance (OTC:RNNCF) Stock

Renaissance Inc is mainly engaged in the operation of sports clubs in Japan. Its business activities include fitness club, swimming school, tennis school, golf school, health promotion business at local governments and enterprises, nursing care rehabilitation business, other related business.

Renaissance Inc

JP Morgan analyst Eric Joseph initiates coverage on Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) with a Overweight rating and announces Price Target of $38.

News

Price Target

Initiation

Analyst Ratings

SEPN

JP Morgan Initiates Coverage On Septerna with Overweight Rating, Announces Price Target of $38

Benchmark analyst Mark Zgutowicz reiterates Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) with a Buy and maintains $51 price target.

Reiteration

CRTO

Benchmark Reiterates Buy on Criteo, Maintains $51 Price Target

Oppenheimer analyst Noah Kaye maintains Vertiv Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Outperform and raises the price target from $121 to $131.

Oppenheimer Maintains Outperform on Vertiv Hldgs, Raises Price Target to $131

Spectral AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDAI#NASDAQ">MDAI</a>) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the successful completion of an approximate $5.0 million equity financing in an at-the-market transaction. The closing is to be completed in two tranches. Part of the proceeds will be used for the retirement of its outstanding obligations with Yorkville Advisors. This transaction supports Spectral AI's growth trajectory and progress toward a submission to the U.S. Food and Drug Administration ("FDA") for approval of its DeepView AI&#xAE;-Burn system, a crucial milestone targeted for the first half of 2025.
The equity financing was made possible through a strategic financing arrangement with institutional investors, a testament to Spectral AI's ability to attract significant financial support. This arrangement, which included an at-the-market offering of equity and pre-funded warrants, strengthens Spectral AI's balance sheet and enhances its operational flexibility as it pursues FDA approval.

Offerings

MDAI

Spectral AI Announces The Successful Completion Of An ~$5M Equity Financing In An At-The-Market Transaction, Strengthening Financial Position For FDA Pathway

Health Care

General

IRIX

Iridex Confirms That Local Coverage Determination L37531, Relating To Micro-Invasive Glaucoma Surgery Was Adopted As Scheduled And wll Be Effective For Services Performed After Nov. 17

Jefferies analyst Michael Prew initiates coverage on InvenTrust Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVT#NYSE">IVT</a>) with a Hold rating and announces Price Target of $33.

Jefferies Initiates Coverage On InvenTrust Properties with Hold Rating, Announces Price Target of $33

Highlights Include Solid Tumor Profiling, Liquid Biopsy Sensitivity, And HPV Subtyping Innovations

Biotech

NeoGenomics To Present Four Studies At AMP 2024 Showcasing ctDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

Benchmark analyst Mark Palmer reiterates Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Buy and maintains $16 price target.

BTDR

Benchmark Reiterates Buy on Bitdeer Technologies, Maintains $16 Price Target

NVNO

enVVeno Medical Submits PMA Application To FDA To Sell And Market VenoValve In The US

Loop Capital analyst Chris Dankert maintains Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) with a Hold and raises the price target from $24 to $26.

Loop Capital Maintains Hold on Kennametal, Raises Price Target to $26

Vipshop Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) reported third-quarter sales of $2.95 billion,&nbsp;down by 9.2% year-on-year, which topped the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42056726/vipshop-reports-unaudited-third-quarter-2024-financial-results" rel="noreferrer noopener">Wall Street view of $2.91 billion</a>.
Vipshop Holdings&nbsp;registered&nbsp;adjusted earnings per ADS of 35 cents, which beat the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of 33 cents</a>.&nbsp;
Total orders for the quarter were 163.9 million,&nbsp;compared with 179.9 million in the prior year period.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42011906/exxon-mobil-set-to-cut-400-texas-jobs-after-pioneer-deal" rel="noreferrer noopener">Exxon Mobil To Cut 400 Texas Jobs In Stages Through 2026</a>
The number of active customers for the third quarter of 2024 was 39.6 million, down from 42.3 million a year ago.
Gross margin for the quarter increased to 24.0% from 23.6% in the prior year period. Gross profit declined 7.9%&nbsp;to&nbsp;4.96 billion Chinese Yuan&nbsp;($706.14 million).
GMV&nbsp;for the quarter was&nbsp;40.1 billion Chinese Yuan versus 42.5 billion Chinese Yuan a year ago.
As of&nbsp;September 30, 2024, the company had cash and cash equivalents, restricted&nbsp;cash&nbsp;of&nbsp;$3.2 billion, and&nbsp;short-term&nbsp;investments of&nbsp;$222.3 million.
During the quarter, the company repurchased&nbsp;$275.0 million&nbsp;of its ADSs under its current&nbsp;$1 billion&nbsp;share repurchase program,&nbsp;effective through&nbsp;March 2025.&nbsp;
Eric Shen, Chairman and CEO of Vipshop, highlighted the company's swift response to address external challenges and seize growth opportunities amidst soft industry trends in discretionary categories during the third quarter. He noted early positive outcomes from adjustments that improved the merchandising portfolio and operational efficiency while driving double-digit growth in active Super VIP customers. 
Despite the slow recovery in consumer spending, he emphasized a continued focus on long-term strategies and executing key retail fundamentals to support sustained growth.
Mark Wang, CFO of Vipshop, underscored the alignment of third-quarter results with expectations, driven by solid profitability through disciplined financial management. He detailed ongoing investments to enhance customer impact and growth while reallocating resources to create a more balanced business model. 
Additionally, he highlighted the company's commitment to shareholder value, with $275 million worth of shares repurchased during the quarter and plans for a new $1 billion repurchase program following the full utilization of the current one.
Outlook:&nbsp;For the fourth quarter of 2024, the company expects its total net revenues of&nbsp;31.2 billion Chinese Yuan &#8211; 32.9 billion Chinese Yuan, representing a <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">year-over-year decrease of approximately 10% &#8211; 5%.&nbsp;</a>
Vipshop Holdings stock plunged over 20% year-to-date.
Price Action: VIPS stock is down 1.66% to $13.65 premarket at last check Tuesday.&nbsp;
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42006281/alibaba-q2-earnings-revenue-beats-forecast-cloud-and-international-sales-shine-free-cash-flow-falls-amid-strategic-investments" target="_blank" rel="noreferrer noopener">Alibaba Q2 Earnings: Revenue Beats Forecast, Cloud and International Sales Shine, Free Cash Flow Falls Amid Strategic Investments</a></li>
</ul>

Earnings

Equities

Guidance

Movers

VIPS

Vipshop Beats Q3 Estimates Despite Sales Dip, Focuses On Long-Term Resilience

&nbsp;Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) today announced the distribution ratio for the previously announced special stock distribution (the "Distribution") to its stockholders of its equity interest in Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>). Based on the shares of Select Medical's common stock outstanding as of November 18, 2024, the record date (the "Record Date") for the Distribution, Select Medical's stockholders will receive 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the close of business on the Record Date.
The Distribution by Select Medical of the special stock distribution will be made on November 25, 2024 (the "Distribution Date") in the form of a pro rata common stock distribution to all of Select Medical's stockholders of record on the Record Date. No fractional shares of Concentra's common stock will be distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received. The Distribution is generally intended to qualify as tax free to Select Medical's stockholders for U.S. federal income tax purposes.
J.P. Morgan and Goldman Sachs are acting as financial advisors to Select Medical in connection with the Distribution. Dechert LLP is acting as legal advisor to Select Medical in connection with the Distribution.

Dividends

Select Medical Holdings Corporation Announces Distribution Ratio For Special Stock Distribution To Stockholders; Stockholders Will Receive 0.806971 Shares Of Concentra's Common Stock For Every Share Of Select Medical's Common Stock Held As Of The Close Of Business On The Record Date

Fiscal 2025 Guidance
S&amp;W expects fiscal 2025 revenue to be within a range of $34.5 to $38 million. This includes approximately $4.1 million of international sales in the just completed first quarter of fiscal 2025. Adjusted EBITDA is expected to be in the range of ($5.0) million to ($3.0) million for fiscal 2025. Adjusted EBITDA for the first quarter of fiscal 2025 was ($3.1) million indicating that the Company expects adjusted EBITDA for the remaining three quarters of the fiscal year to be in a range of ($1.9) to $0.1 million.

SANW

S&W Seed 2025 Guidance: Expects Revenue Of $34.5M-$38M; Sees Adjusted EBITDA Of ($5.0)M-($3.0)M

Northern Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTIC#NASDAQ">NTIC</a>) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.19 by 5.26 percent. This is a 566.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $23.35 million which beat the analyst consensus estimate of $22.50 million by 3.77 percent. This is a 12.74 percent increase over sales of $20.71 million the same period last year.

Earnings Beats

NTIC

Northern Technologies Q4 Adj $0.20 Beats $0.19 Estimate, Sales $23.35M Beat $22.50M Estimate

Buybacks

CTVA

Corteva Agriscience Announces $3B Share Repurchase Program

Jefferies analyst Roger Song upgrades Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) from Hold to Buy and raises the price target from $2 to $7.

Upgrades

ACRS

Jefferies Upgrades Aclaris Therapeutics to Buy, Raises Price Target to $7

Akari Therapeutics, Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTX#NASDAQ">AKTX</a>) announces receipt of written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC informing the Company that its deficiency under Listing Rule 5550(b) has been cured. The Company is now in full compliance with all Nasdaq continued listing requirements.
Based on the foregoing, the previously scheduled Nasdaq hearing before the Hearings Panel on November 21, has been cancelled. The Company will continue to be traded on The Nasdaq Capital Market.

AKTX

Akari Therapeutics Regains Full Nasdaq Compliance, Shareholders Equity Deficiency Has Been Cured

WIIM

SPAI

Safe Pro Group shares are trading higher. The company issued expectations for a year-over-year increase in its Q4 revenue.

Professional Diversity Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>), ("IPDN" or the "Company"), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse individuals, today announced that it has entered into a securities purchase agreement with a single institutional investor for the issuance and sale of 2,500,000 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.80 per share.
In a concurrent private placement, the Company also agreed to issue to the same investor series A common stock purchase warrants (the "Series A Warrants") to purchase up to 2,500,000 shares of common stock and series B common stock purchase warrants (the "Series B Warrants") to purchase up to 2,500,000 shares of common stock (the Series A Warrants together with the Series B Warrants, the "Common Warrants"). The Series A Warrants will have an exercise price of $0.86 per share, will be exercisable commencing six months from the date of issuance, and will expire five and one-half years following the date of issuance. The Series B Warrants will have an exercise price of $0.86 per share, will be exercisable commencing six months from the date of issuance, and will expire twenty-four months following the date of issuance.
The gross proceeds from the offerings, before deducting the placement agent's fees and other offering expenses payable by the Company, are expected to be approximately $2 million. The Company expects to use the net proceeds from the offerings for general working capital.
A.G.P./Alliance Global Partners is acting as sole placement agent for the offerings. The offerings are expected to close on or about November 20, 2024, subject to the satisfaction of customary closing conditions.

IPDN

Professional Diversity Network Announces Pricing Of $2M Registered Direct Offering With A Single Investor For The Issuance And sale Of 2.5M Shares Of Common Stock At A Price Of $0.80/Share, And Concurrent Private Placement

<a href="https://open.substack.com/pub/europeancapitalinsights/p/russian-stocks-get-much-needed-bump?r=3nmatg&amp;utm_campaign=post&amp;utm_medium=web">Russian stocks climbed after Donald Trump</a> won the US presidential elections on November 5 on hopes that a new administration in Washington will try to end Moscow's war in Ukraine.
Trump has promised to try to end the war in Ukraine despite the challenges of resolving the bitter conflict. The president could also improve relations between the US and Russia if a peace settlement is reached. This would benefit Russian businesses struggling under stiff Western-led sanctions.
State-owned energy corporation <a href="https://www.finam.ru/quote/moex/gazp/?go=comment">Gazprom</a> (up 2.6%) and state airline <a href="https://www.finam.ru/quote/moex/aflt/">Aeroflot</a> (up 3.8%) rose on November 7 after Trump won the election. The Russian stock index, MOEX, <a href="https://tradingeconomics.com/russia/stock-market">climbed</a> nearly 2% from November 5 to 6, peaking at <a href="https://tradingeconomics.com/russia/stock-market">2,785 on November 11</a>.
<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" width="1200" height="832" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1.png" alt="" class="wp-image-3437" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-300x152.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-1024x520.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-768x390.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
Gazprom, Aeroflot Russian stock prices, October 18-November 18, 2024, Source: <a href="https://tradingeconomics.com/gazp:rm">Tradingeconomics</a>
After President Vladimir Putin sent troops into Ukraine in 2022, the US and its allies imposed sweeping sanctions against Russia. They forced companies to cut back on business ties and divest from assets. Western companies that kept significant operations there have also seen their valuations pressured, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-07/russia-linked-stocks-surge-on-nearby-markets-since-trump-win">reported</a>.&nbsp;
<h3 class="wp-block-heading">Shares In Companies with Russian Business Rose</h3>
Shares in companies that have interests in Russia also jumped after the Trump win. Optimism about a de-escalation in the Russia-Ukraine conflict caused the rally.&nbsp;
Vienna-based Raiffeisen Bank International AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RAIFF#OTC">RAIFF</a>) gained over 15% between November 4 and 7. Hungary's budget airline Wizz Air Holdings Plc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/WZZZY#OTC">WZZZY</a>), listed on the London Stock Exchange (<a href="https://www.londonstockexchange.com/stock/WIZZ/wizz-air-holdings-plc/company-page">LSE</a>), gained over 10% in the few days following the election from 1375p to 1567p on November 11.
In Turkey, construction company Enka Insaat (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EKIVF#OTC">EKIVF</a>) was up  7.4% the day after the election, and beer maker Anadolu Efes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AEBZY#OTC">AEBZY</a>) advanced 24.30% from November 5 to 14.
Conversely, the Shanghai Stock Exchange Index, which rallied around 40% following the government&#8217;s intervention in September, lost more than 6% following the election on concerns of a renewed trade war with the US.
Senator Marco Rubio, Trump's nominee to serve as secretary of state, and Republican Mike Waltz, his national security advisor, are considered China hawks. In 2021, <a href="https://foreignpolicy.com/2024/11/15/rubio-waltz-china-xinjiang-uyghurs-human-rights/">Waltz called for the US</a> to boycott the Beijing Winter Olympics the following year over China's human rights record, <a href="https://waltz.house.gov/news/documentsingle.aspx?DocumentID=482">likening the event</a> to the infamous 1936 Summer Games that were held in Nazi Germany.
<h3 class="wp-block-heading">Russia Central Bank Hikes Key Interest Rate&nbsp;&nbsp;</h3>
Despite the post-election bump, the Russian stock index has steadily fallen since July 2024 as business struggles with the reality of a war-time economy. The Russian ruble traded below a one-year low against the dollar on Monday. It is down about 10% for the last 12&nbsp; months.&nbsp;&nbsp;&nbsp;
<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" width="1200" height="609" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1.png" alt="" class="wp-image-3436" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-300x152.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-1024x520.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125631/image-1-768x390.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
RUB/USD, Source: <a href="https://www.tradingview.com/chart/Fl8iqpOT/?symbol=FX_IDC%3ARUBUSD">Trading View</a>
Russians are also getting hit hard by inflation as the Kremlin pours billions of rubles into military industries. Russia boosted defense by 25% in 2025 to 6.3% of GDP, <a href="https://www.reuters.com/world/europe/russia-hikes-national-defence-spending-by-23-2025-2024-09-30/">Reuters reported</a>, citing draft budget documents.
In September, the current seasonally adjusted price growth rose to 9.8% in annualized terms from 7.5% in August. In response,&nbsp; the Bank of Russia raised on October 25 <a href="https://www.cbr.ru/eng/press/pr/?file=25102024_133000Key_eng.htm">its key interest rate by 200 basis points</a> on October 25 from 19% to 21%, above expectations of 100 basis points.&nbsp;
<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" width="1200" height="569" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125630/image.png" alt="" class="wp-image-3435" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125630/image.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125630/image-300x142.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125630/image-1024x486.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/19125630/image-768x364.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
Russia Interest Rate, 2022-2024, Source: <a href="https://tradingeconomics.com/russia/interest-rate">Trading Economics</a>&nbsp;
"We have been forced into beginning a monetary tightening cycle," Elvira Nabiullina, Russian central bank governor, <a href="https://www.cbr.ru/eng/press/event/?id=21126">said </a>on October 31. "Businesses are concerned about the implications for investment, production capabilities and economic growth. Households are concerned about when we will be able to tame growing prices."
Outside the defense industries, companies can't compete for workers without paying higher wages. In turn, they are charging higher prices, CNN <a href="https://edition.cnn.com/2024/11/18/economy/russia-inflation-new-heights-intl-analysis/index.html">reported</a>. News agencies have <a href="https://www.ft.com/content/659bb41c-d6f1-4690-8193-647f549d5133">reported a spike in the theft of butter</a>, highlighting the wartime economy's impact on prices.
<h3 class="wp-block-heading">Russian Businesses Struggle With Higher Rates</h3>
Monetary policy may not be enough to slow inflation, with Russia spending Soviet-level amounts on defense and security. Sergey Chemezov, head of the state-owned defense conglomerate Rostec, warned that "even arms sales don't generate enough profit" to cover the debt with rates at 21%.&nbsp;
&nbsp;"At the current interest rate, it's more profitable for companies to halt expansion or even downsize and put funds in the bank rather than continue operations," Russian billionaire Alexey Mordashov <a href="https://meduza.io/en/feature/2024/11/08/as-corporate-debts-in-russia-balloon-under-rising-interest-rates-a-wave-of-bankruptcies-could-be-on-the-horizon">said.</a> He is the majority shareholder in the steel company Severstal.
Oleg Kuzmin, an economist at Renaissance Capital, warned that highly leveraged companies face heightened risks. Russian firms typically rely <a href="https://www.the-express.com/news/world-news/154427/russian-corporate-debt-crisis-widespread-bankruptcies">on new loans to pay off existing debt</a>, but the strategy has become difficult with current interest rates, he added.
Peak economic growth in Russia "passed most likely in the middle of this year," Kuzmin <a href="https://www.russiamatters.org/news/russia-review/russia-review-oct-18-25-2024">said</a>.
Disclaimer:
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content&nbsp;or&nbsp;accuracy.

Comments

Renaissance

News

Latest news for Renaissance (OTC:RNNCF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga